| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3418550 | A | Drug level in dog liver microsomes treated with 5-(8-Fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method | Canis lupus familiaris | 2 | assay format | Scientific Literature | ||
| 2. | ALA3420264 | A | Drug level in human liver microsomes treated with 5-(8-Fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method | Homo sapiens | 2 | assay format | Scientific Literature | ||
| 3. | ALA3420265 | A | Drug level in rat liver microsomes treated with 5-(8-Fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method | Rattus norvegicus | 2 | assay format | Scientific Literature | ||
| 4. | ALA3420266 | A | Drug level in monkey liver microsomes treated with 5-(8-Fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method | Macaca mulatta | 2 | assay format | Scientific Literature | ||
| 5. | ALA3420267 | A | Drug level in mouse liver microsomes treated with 5-(8-Fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method | Mus musculus | 2 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!